2.0200
+0.0300
+(1.51%)
At close: January 10 at 10:17:28 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,541.0000
-21,541.0000
-21,794.0000
-11,257.0000
-14,012.0000
Investing Cash Flow
-10,514.0000
-10,514.0000
-13.0000
-28.0000
-640.0000
Financing Cash Flow
24,157.0000
24,157.0000
33,381.0000
-827.0000
-90.0000
End Cash Position
18,562.0000
18,562.0000
26,555.0000
14,661.0000
26,306.0000
Capital Expenditure
-514.0000
-514.0000
-13.0000
-28.0000
-640.0000
Issuance of Capital Stock
26,346.0000
26,346.0000
36,000.0000
1,144.0000
--
Free Cash Flow
-22,055.0000
-22,055.0000
-21,807.0000
-11,285.0000
-14,652.0000
12/31/2020 - 10/30/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SG7.MU Sage Therapeutics Inc
5.73
0.00%
41O.F Outlook Therapeutics, Inc.
2.0600
+0.98%
6C1.SG CytomX Therapeutics Inc
0.8410
-9.52%
4A3.F Immatics N.V.
6.84
+1.71%
BIOVIC-B.ST Biovica International AB (publ)
1.9400
+8.87%
BVNKF Bavarian Nordic A/S
26.25
0.00%
TRML Tourmaline Bio, Inc.
19.70
-1.50%
CBUS Cibus, Inc.
2.4000
-6.80%
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
KRRO Korro Bio, Inc.
35.26
-6.27%